Former senior executive, Merck & Co., Inc.
David W. Anstice was the Deputy Chair of the US Studies Centre's Board of Directors.
He retired as a senior executive of Merck & Co., Inc., in September 2008. He had reported to Merck's CEO, in various assignments, including President, The Americas; President, Asia Pacific; and President, Japan, since 1994. Merck is a world leader in the discovery, development, manufacture and marketing of prescription medicines and vaccines. He served on Merck's Executive Committee, the Company's senior management team commencing in 1990. Today, he is a non-executive Director of two companies, CSL Limited, based in Melbourne, Australia (ASX), and Alkermes, based in Cambridge, Massachusetts (NASDAQ).
David is Chairman and President of the University of Sydney USA Foundation (a US based fund raising group), was awarded an Honorary Fellowship of the University of Sydney in 2007, is a Member of the United States Advisory Council of the American Australian Association in New York, and is a Member of the Global Advisory Board of ADVANCE in New York. He is a member of the Board of Managers of the Morris Arboretum of the University of Pennsylvania, and the Board of the Foundation of the University of the Valley of Guatemala.
An Economics graduate of the University of Sydney in Australia, Mr. Anstice joined Merck in 1974, in Australia. He progressed through a series of positions, and on several continents, including Managing Director, Merck Sharp & Dohme Australia; Vice President, International Human Health Marketing, Merck Sharp & Dohme International; President, U.S. Human Health; President, Human Health Europe; President, Human Health, The Americas; from 2000 until July 2006, he was responsible for Merck's joint ventures with Schering-Plough, and from January 2002 to July 2005 he was responsible for Merck's human health businesses in Canada, Latin America, Japan, Australia and New Zealand, and until September 2006, Mr. Anstice was President, Asia Pacific Human Health, responsible for Japan, China, Australia, Korea, and other Asia Pacific country human health pharmaceutical business of Merck & Co., Inc. During 2007, he acted as President, Global Human Health and President, Banyu Pharmaceuticals, responsible for all Merck's business in Japan, on short term assignments.
He served as Chairman of the National Pharmaceutical Council, Reston, Virginia in 1997, and represented Merck on the Board of Directors, Biotechnology Industry Organization in Washington, D.C. from 1996 to 2005.
He resides in Montgomery County, Pennsylvania, with his wife, Ana-Maria Zaugg.